Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Vertex Pharmaceuticals Incorporated
Related studies linked through entity extraction aliases.
VX-950 and Peginterferon for Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765
- Status
- COMPLETED
- Phase
- PHASE2
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2